First clinical experience with a new TCR/CD3-monoclonal antibody (BMA 031) in kidney transplant patients.
Land
W
W
Hillebrand
G
G
Illner
W D
WD
Abendroth
D
D
Hancke
E
E
Schleibner
S
S
Hammer
C
C
Racenberg
J
J
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000945:Antigens, Differentiation, T-Lymphocyte; D001379:Azathioprine / Q000627:therapeutic use; D017252:CD3 Complex; D002452:Cell Count; D003524:Cyclosporins / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000378:metabolism; D008775:Methylprednisolone / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D003524:Cyclosporins; D011948:Receptors, Antigen, T-Cell; D001379:Azathioprine; D008775:Methylprednisolone